This site is intended only for healthcare professionals resident in Thailand

Search

Menu

Close

Sign InLog Out Our medicinesTherapy areasExplore contentExplore contentEventsDownloadable materialsVideosLet’s connectLet's ConnectContact usAsk a questionPfizer medical information

Menu

Close

Supporting ResourcesEventsMaterialsVideosAboutAboutCOVID-19 overviewLong COVIDMechanism of diseaseTransmissionVariantsPreparePrepareVaccination overviewVaccination typesWaning & boostingGuidelines for managing COVID-19DiagnoseDiagnoseSigns & symptomsHigh risk patientsTestingTreatTreatTreatment guidelinesTreatment optionsSupporting ResourcesSupporting ResourcesEventsMaterialsVideos
COVID-19 overview.COVID-19 history and numbers

On 11 February 2020, World Health Organization (WHO) officials announced a new infectious disease named coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).1,2

Find out how COVID-19 got its name
  • Guidelines agreed by the WHO, the World Organisation for Animal Health, and the Food and Agriculture Organization of the United Nations stated that the disease name must:1
    • Be pronounceable
    • Be related to the disease
    • Not refer to a geographical location, animal, individual, or group of people
  • COVID-19 naming:2
    • CO Corona
    • VI Virus
    • D Disease
    • 19 2019 (year of first diagnosis)

At 09 October 2022, 634,271,972​ cases of COVID-19 have been reported globally (please refer to Johns Hopkins Coronavirus Resource Center for the latest data).3

The burden of disease for patients and healthcare services

SARS-CoV-2 infection can have a serious impact on patients and healthcare systems.4,5

The burden of disease for patientsThe burden of disease for healthcare servicesOngoing management of COVID-19

COVID-19 is predicted to be an enduring health issue.9

To minimise the burden of disease for both patients and healthcare systems, it is necessary to ensure the availability of:

  • vaccinations10
  • rapid testing10
  • early intervention treatments11
Rapid testing and diagnosis allow early intervention and can be key to pandemic control.12
Explore morePrepare

Find out more about different vaccine types, waning immunity, and boosting by clicking on the buttons below.

Vaccine types
Loading
Waning & boosting
Loading
Guidelines for
managing COVID-19
LoadingReferencesReferences:WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020. Available from: www.who.int/director-general/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020. Accessed: September 2022. CDC. Basics of COVID-19. Available from: www.cdc.gov/coronavirus/2019-ncov/your-health/about-covid-19/basics-covid-19.html. Accessed: September 2022.Johns Hopkins Coronavirus Resource Center. COVID-19 Dashboard: https://coronavirus.jhu.edu/map.html. Accessed: October 2022.CDC. COVID-19 People with Certain Medical Conditions. Available at: www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html.  Accessed: September 2022.WHO. COVID-19 significantly impacts health services for noncommunicable diseases. Available at: www.who.int/news/item/01-06-2020-covid-19-significantly-impacts-health-services-for-noncommunicable-diseases. Accessed: September 2022. Ayoubkhani D, et al. BMJ 2021;372:n693.Estiri H, et al. Sci Rep 2021;11:5322.Goyal DK, et al. Clinical Medicine 2020;20(3):248-50.Scudellari M. Nature 2021;584:22–5.CDC. https://www.cdc.gov/coronavirus/2019-ncov/global-covid-19/global-response-strategy.html. Accessed: October 2022.NHS. https://www.nhs.uk/conditions/coronavirus-covid-19/self-care-and-treatments-for-coronavirus/treatments-for-coronavirus/. Accessed: October 2022.CDC. Overview of Testing for SARS-CoV-2 (COVID-19). Available at:  www.cdc.gov/coronavirus/2019-ncov/hcp/testing-overview.html. Accessed: September 2022.About High risk patients

Find out more about patients who are at higher risk of progression to severe COVID-19

 Learn more Loading Treatment options for COVID-19

Find out about the therapeutic targets in the viral lifecycle

 Learn more Loading
PP-CVV-THA-0392

Adverse events should be reported. Reporting forms and information can be found at https://www.pfizersafetyreporting.com/#/en

 

PfizerPro AccountPfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign inRegisterAccountSign Out

This website is intended only for healthcare professionals registered in Thailand. If you are a non-registered healthcare professional in Thailand wishing to access general health and medical information, please visit [www.pfizer.co.th].

This website is brought to you by Pfizer (Thailand) Limited. 
 
You are now leaving the PfizerPro Thailand website
 ​
You are being directed to a third-party website. Please note that this third-party website is not controlled by PfizerPro Thailand or subject to our privacy policy. Thank you for visiting our site. We hope your visit was informative and enjoyable.
PP-UNP-THA-0485​
You are now leaving the PfizerPro Thailand website You are being directed to a third-party website. Please note that this third-party website is not controlled by PfizerPro Thailand or subject to our privacy policy. Thank you for visiting our site. We hope your visit was informative and enjoyable.